GSK offers concessions to address EU concerns over their Pfizer deal
GSK offers concessions to address EU concerns over their Pfizer deal

GSK offers concessions to address EU concerns over their Pfizer deal

GlaxoSmithKline has worked concessions to deal with EU antitrust problems over its organized joint venture with Pfizer’s customer health and wellness business, the European Commission claimed on Thursday.

GSK announced the sale December last year, a step which will put it ahead of opponents Johnson & Johnson, Bayer and also Sanofi.

The EU competition enforcer will make a decision by July 10 whether to accept the proposal, demand extra or open a major investigation, according to a declaring on its site.

Leave a Reply